Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumors

Human Pathology

Volumn 42, Issue 11, 2011, Pages 1667-1675

  Schildhaus, Hans Ulrich ^a   Riegel, Raffael ^a   Hartmann, Wolfgang ^a   Steiner, Susanne ^a   Wardelmann, Eva ^a   Merkelbach Bruse, Sabine ^a   Tanaka, Shinya ^b   Sonobe, Hiroshi ^c   Schüle, Roland ^d   Buettner, Reinhard ^a   Kirfel, Jutta ^a  

^a UNIVERSITY OF BONN   (Germany)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Chungoku Central Hospital   (Japan)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Histone demethylase; LSD1 inhibition; Lysine specific demethylase 1; Mesenchymal tumors

Indexed keywords

BIOLOGICAL MARKER; HISTONE H3; HISTONE LYSINE METHYLTRANSFERASE; LYSINE SPECIFIC DEMETHYLASE 1; MOLECULAR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CONTROLLED STUDY; DESMOPLASTIC SMALL ROUND CELL TUMOR; ENZYME INHIBITION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PERIPHERAL NERVE TUMOR; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; SARCOMA; SOLITARY FIBROUS TUMOR; SYNOVIAL SARCOMA;

CELL LINE, TUMOR; CLORGYLINE; DESMOPLASTIC SMALL ROUND CELL TUMOR; EPIGENESIS, GENETIC; HISTONE DEMETHYLASES; HUMANS; MONOAMINE OXIDASE INHIBITORS; NERVE SHEATH NEOPLASMS; RHABDOMYOSARCOMA; SARCOMA, SYNOVIAL; SOLITARY FIBROUS TUMORS; TRANYLCYPROMINE; TUMOR MARKERS, BIOLOGICAL;

EID: 80054684268     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.12.025     Document Type: Article

References (29)

1. T. Kouzarides Chromatin modifications and their function Cell 128 2007 693 705 (Pubitemid 46273577)
2. Y. Shi, F. Lan, and C. Matson Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 Cell 119 2004 941 953 (Pubitemid 40037608)
3. Y. Shi, and J.R. Whetstine Dynamic regulation of histone lysine methylation by demethylases Mol Cell 25 2007 1 14 (Pubitemid 46049067)
4. Y.J. Shi, C. Matson, F. Lan, S. Iwase, T. Baba, and Y. Shi Regulation of LSD1 histone demethylase activity by its associated factors Mol Cell 19 2005 857 864 (Pubitemid 41316679)
5. M.G. Lee, C. Wynder, D.M. Schmidt, D.G. McCafferty, and R. Shiekhattar Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications Chem Biol 13 2006 563 567
6. E. Metzger, M. Wissmann, and N. Yin LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription Nature 437 2005 436 439 (Pubitemid 41613508)
7. E. Metzger, A. Imhof, and D. Patel Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4 Nature 464 2010 792 796
8. I. Garcia-Bassets, Y.S. Kwon, and F. Telese Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors Cell 128 2007 505 518 (Pubitemid 46198894)
9. J. Wang, K. Scully, and X. Zhu Opposing LSD1 complexes function in developmental gene activation and repression programmes Nature 446 2007 882 887 (Pubitemid 46633160)
10. P. Kahl, L. Gullotti, and L.C. Heukamp Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence Cancer Res 66 2006 11341 11347 (Pubitemid 46009965)
11. J.H. Schulte, S. Lim, and A. Schramm Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy Cancer Res 69 2009 2065 2071
12. S. Lim, A. Janzer, and A. Becker Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology Carcinogenesis 31 2010 512 520
13. S. Lim, E. Metzger, R. Schule, J. Kirfel, and R. Buettner Epigenetic regulation of cancer growth by histone demethylases Int J Cancer 127 2010 1991 1998
14. S. Grant Targeting histone demethylases in cancer therapy Clin Cancer Res 15 2009 7111 7113
15. C.D.M. Fletcher, K.K. Unni, and F. Mertens Pathology and genetics of tumors of soft tissue and bone 2002 IARC Lyon
16. C.D. Fletcher, J.J. Berman, and C. Corless Diagnosis of gastrointestinal stromal tumors: a consensus approach Hum Pathol 33 2002 459 465 (Pubitemid 34747864)
17. H. Sonobe, Y. Manabe, and M. Furihata Establishment and characterization of a new human synovial sarcoma cell line, HS-SY-II Lab Invest 67 1992 498 505
18. T. Hosono, M. Hironaka, and A. Kobayashi Primary pulmonary synovial sarcoma confirmed by molecular detection of SYT-SSX1 fusion gene transcripts: a case report and review of the literature Jpn J Clin Oncol 35 2005 274 279 (Pubitemid 41444295)
19. Y. Xie, B. Skytting, and G. Nilsson SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X;18)(p11.2;q11.2) translocation Cancer Res 62 2002 3861 3867 (Pubitemid 34728873)
20. T. Watanabe, M. Tsuda, and Y. Makino Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines Mol Cancer Res 4 2006 499 510 (Pubitemid 44197045)
21. A. Kawai, N. Naito, and A. Yoshida Establishment and characterization of a biphasic synovial sarcoma cell line, SYO-1 Cancer Lett 204 2004 105 113 (Pubitemid 38117199)
22. W.S. Xu, R.B. Parmigiani, and P.A. Marks Histone deacetylase inhibitors: molecular mechanisms of action Oncogene 26 2007 5541 5552 (Pubitemid 47255934)
23. S.K. Patra, and S. Bettuzzi Epigenetic DNA-(cytosine-5-carbon) modifications: 5-aza-2′-deoxycytidine and DNA-demethylation Biochemistry (Mosc) 74 2009 613 619
24. Y. Huang, T.M. Stewart, and Y. Wu Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes Clin Cancer Res 15 2009 7217 7228
25. Y. Huang, E. Greene, and T. Murray Stewart Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes Proc Natl Acad Sci U S A 104 2007 8023 8028 (Pubitemid 47185869)
26. M. Wissmann, N. Yin, and J.M. Muller Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression Nat Cell Biol 9 2007 347 353
27. S. Hamada, T. Suzuki, and K. Mino Design, synthesis, enzyme-inhibitory activity, and effect on human cancer cells of a novel series of jumonji domain-containing protein 2 histone demethylase inhibitors J Med Chem 53 2010 5629 5638
28. J.M. Mosquera, and C.D. Fletcher Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component-is this dedifferentiated SFT? Am J Surg Pathol 33 2009 1314 1321
29. A.L. Folpe, and D. Kwiatkokowski Perivascular epitheliod cell neoplasms: pathology and pathogenesis Hum Pathol 41 2010 1 15